MoonLake Immunotherapeutics (MLTX) Pension (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) posted quarterly Pension of $353000.0 for Q1 2026, down 34.14% year-over-year from $536000.0 in Q1 2025, and down 35.7% quarter-over-quarter from $549000.0 in Q3 2025.
Analysis
MoonLake Immunotherapeutics (MLTX) Pension (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Pension history runs 6 years deep, the most recent figure standing at $353000.0 for Q1 2026.
- In Q1 2026, Pension fell 34.14% year-over-year to $353000.0; the TTM figure through Mar 2026 stood at $353000.0 (down 34.14% YoY), while the FY2024 annual figure was $621000.0, down 75.1% from the prior year.
- Pension for Q1 2026 stood at $353000.0, down from $549000.0 in the prior quarter.
- The five-year high for Pension was $2.5 million in Q4 2023, with the low at $4985.0 in Q3 2022.
- The 5-year median for Pension is $536000.0 (2025), against an average of $604359.1.
- The sharpest annual moves came in 2023 and 2024: Pension surged 5023.35% in 2023, then plunged 75.1% in 2024.
- MoonLake Immunotherapeutics' Pension stood at $1.3 million in 2022, then soared by 88.65% to $2.5 million in 2023, then slumped by 75.1% to $621000.0 in 2024, then retreated by 11.59% to $549000.0 in 2025, then sank by 35.7% to $353000.0 in 2026.
- Business Quant data shows MLTX's Pension at $353000.0 in Q1 2026, $549000.0 in Q3 2025, and $574000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | MoonLake Immunotherapeutics | 1.11 Bn | 572.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74,000.00 |
| Mar 31, 2026 | 353,000.00 |
| Sep 30, 2025 | 549,000.00 |
| Jun 30, 2025 | 574,000.00 |
| Mar 31, 2025 | 536,000.00 |
| Dec 31, 2024 | 621,000.00 |
| Sep 30, 2024 | 694,959.00 |
| Jun 30, 2024 | 541,949.00 |
| Mar 31, 2024 | 462,735.00 |
| Dec 31, 2023 | 2.49 Mn |
| Sep 30, 2023 | 255,399.00 |
| Jun 30, 2023 | 323,597.00 |
| Mar 31, 2023 | 314,174.00 |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 4,985.00 |
| Jun 30, 2022 | 18,588.00 |
| Dec 31, 2021 | 1.32 Mn |